Literature DB >> 2541962

Urinary excretion of meso-2,3-dimercaptosuccinic acid in human subjects.

H V Aposhian1, R M Maiorino, R C Dart, D F Perry.   

Abstract

The urinary excretion of meso-2,3-dimercaptosuccinic acid (DMSA), which is an effective chelating agent for lead, was determined after the oral administration of 10 mg DMSA/kg to six normal young men. The DMSA that was absorbed was extensively biotransformed. After 14 hours only 2.53% of the administered DMSA was excreted in the urine as unaltered DMSA and 18.1% as altered forms. The unaltered DMSA was 12% of the total DMSA found in the urine. The altered form(s) of DMSA was 88% of the total urinary DMSA. The altered DMSA can be converted to unaltered DMSA by electrolytic reduction, which indicates that the altered forms of DMSA are disulfides. The excretion of altered DMSA reached a peak between 2 and 4 hours after DMSA administration. There were small but statistically significant increases in the excretion of zinc, copper, and lead after DMSA administration. DMSA did not influence the urinary excretion of 27 other metals and elements.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2541962     DOI: 10.1038/clpt.1989.67

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  14 in total

Review 1.  The scientific basis for chelation: animal studies and lead chelation.

Authors:  Donald Smith; Barbara J Strupp
Journal:  J Med Toxicol       Date:  2013-12

2.  delta-Aminolevulinic acid dehydratase genotype modifies four hour urinary lead excretion after oral administration of dimercaptosuccinic acid.

Authors:  B S Schwartz; B K Lee; W Stewart; P Sithisarankul; P T Strickland; K D Ahn; K Kelsey
Journal:  Occup Environ Med       Date:  1997-04       Impact factor: 4.402

3.  Lead poisoning: case studies.

Authors:  J N Gordon; A Taylor; P N Bennett
Journal:  Br J Clin Pharmacol       Date:  2002-05       Impact factor: 4.335

4.  Provocative chelation with DMSA and EDTA: evidence for differential access to lead storage sites.

Authors:  B K Lee; B S Schwartz; W Stewart; K D Ahn
Journal:  Occup Environ Med       Date:  1995-01       Impact factor: 4.402

Review 5.  The current role of 2,3-dimercaptosuccinic acid (DMSA) in the management of childhood lead poisoning.

Authors:  D E Glotzer
Journal:  Drug Saf       Date:  1993-08       Impact factor: 5.606

Review 6.  Mechanisms of divalent metal toxicity in affective disorders.

Authors:  Archita Venugopal Menon; JuOae Chang; Jonghan Kim
Journal:  Toxicology       Date:  2015-11-10       Impact factor: 4.221

Review 7.  Chelation in metal intoxication.

Authors:  Swaran J S Flora; Vidhu Pachauri
Journal:  Int J Environ Res Public Health       Date:  2010-06-28       Impact factor: 3.390

8.  Succimer chelation improves learning, attention, and arousal regulation in lead-exposed rats but produces lasting cognitive impairment in the absence of lead exposure.

Authors:  Diane E Stangle; Donald R Smith; Stephane A Beaudin; Myla S Strawderman; David A Levitsky; Barbara J Strupp
Journal:  Environ Health Perspect       Date:  2006-10-30       Impact factor: 9.031

9.  Mobilization of mercury and arsenic in humans by sodium 2,3-dimercapto-1-propane sulfonate (DMPS).

Authors:  H V Aposhian
Journal:  Environ Health Perspect       Date:  1998-08       Impact factor: 9.031

10.  Use of the Caco-2 cell model to assess the relative lead-chelating ability of diasterioisomers of 2,3-dimercaptosuccinic acid.

Authors:  E A Pigman; J R Lott; Q Fernando; J Blanchard
Journal:  Environ Health Perspect       Date:  1999-02       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.